There is new evidence that the rate at which mesothelioma tumors metabolize glucose could provide significant prognostic information for mesothelioma patients and their doctors.
Pleural mesothelioma is an especially fast-growing asbestos-linked malignancy. It typically carries a grim prognosis but several factors can impact mesothelioma survival, including tumor characteristics that can only be measured using advanced PET/CT imaging. Now, researchers in Japan say one of those characteristics, known as total lesion glycolysis (TLG), is especially valuable for determining mesothelioma prognosis. Read more.